GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SEEGENE Inc (XKRX:096530) » Definitions » Deferred Tax

SEEGENE (XKRX:096530) Deferred Tax : ₩2,107 Mil (TTM As of Jun. 2024)


View and export this data going back to 2010. Start your Free Trial

What is SEEGENE Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

SEEGENE's change in deferred tax for the three months ended in Jun. 2024 was ₩4,763 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Jun. 2024 was ₩2,107 Mil.

SEEGENE Deferred Tax Historical Data

The historical data trend for SEEGENE's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SEEGENE Deferred Tax Chart

SEEGENE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only 994.75 165,991.68 151,595.62 43,127.07 -2,146.62

SEEGENE Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,603.27 -525.96 -632.47 -1,496.90 4,762.68

SEEGENE Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩2,107 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SEEGENE Deferred Tax Related Terms

Thank you for viewing the detailed overview of SEEGENE's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

SEEGENE Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SEEGENE Inc (XKRX:096530) » Definitions » Deferred Tax
Comparable Companies
XKRX:085660 XKRX:016790 XKRX:141080 XKRX:064550 XKRX:298380 XKRX:005250 XKRX:214450 XKRX:950160 XKRX:950210 XKRX:087010 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
Taewon Building 65-5 Bangyi-Dong, Songpa-gu, Seoul, KOR, 138-050
Website
http://www.seegene.co.kr
SEEGENE Inc is engaged in the healthcare sector. The Korean firm specializes in developing upgraded technology for accurate diagnosis of various diseases. Its products include pathogen inspection solutions such as respiratory, gastrointestinal, tuberculosis and meningitis pathogens.

SEEGENE Headlines

No Headlines